Novartis: OmalizumabAchieved all Targets in Phase III Safety Registration

Novartis: OmalizumabAchieved all Targets in Phase III Safety Registration

An announcement made by the Swiss drugmaker Novartis AG (NVS: Quote) on Wednesday suggested about the late-breaking results omalizumab clearing all the primary and secondary endpoints of a pivotal Phase III safety registration study in chronic spontaneous urticaria or CSU.

It is a chronic and debilitating form of hives with partial approved treatment options. GLACIAL is considered as the second of three pivotal Phase III studies. These studies conduct analysis about the efficacy and safety of omalizumab in CSU.

The result derived from the study supported supported the efficacy, safety and tolerability of omalizumab in patients with refractory CSU. It is a kind of chronic and debilitating skin disease with obstinate itch and hives.

Near about 40 percent of CSU patients were unsuccessful on ntihistamines. These include those who were taking the approved dose even for the fourth time. The doses, in terms of official regulations are currently available only for treatment for CSU.

However, Omalizumab is presently not at all approved or indicated for CSU. Supervision of the submissions for omalizumab in CSU is scheduled for later times in the current year. It is a collaborated effort of Novartis and Genentech, Inc.

The data was brought forward for the first time at the European Academy of Allergy and Clinical Immunology-World Allergy Organization World Allergy and Asthma Congress 2013 in Milan which is located in Italy.


FrenchTribune Specials

Dr.Squyres describe Mars rovers’ journey

Dr. Steven Squyres, who is the Principal Scientific Investigator of the Mars Exploration Rover Mission, has described the various aspects surrounding Mars rovers' journeys.

Dr. Squyres was invited as part of the Institutes'sCenter for Space Technology and Research distinguished lecture series for sharing his experience about performing...

Most Popular

Researchers discover new species of Lizards

According to reports, three new species of lizards have...

Climate Change to cause Bleaching Outbreaks around Florida’s southern coasts by

Florida's coral reefs could be hit by widespread coral...

Canada to Provide $243.5 Million towards Thirty Metre Telescope Project

Late Monday, Prime Minister Stephen Harper said that...

Little Foot was 3.67 Million Years old, believe Scientists

Twenty-one years ago a skeleton was found in South...

Poll

Can Greece Come out of Economic Problems: